Y030-1125 Screening compound: N-(1,3-benzothiazol-2-yl)-2-chlorobenzamide

Y030-1125 Screening compound: N-(1,3-benzothiazol-2-yl)-2-chlorobenzamide
Y030-1125 Screening compound: N-(1,3-benzothiazol-2-yl)-2-chlorobenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y030-1125
N-(1,3-benzothiazol-2-yl)-2-chlorobenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y030-1125

Molecular Formula

C14H9ClN2OS (C14 H9 ClN2 OS)

Compound Name

N-(1,3-benzothiazol-2-yl)-2-chlorobenzamide

IUPAC name

N-(13-benzothiazol-2-yl)-2-chlorobenzamide

SMILES

O=C(c(cccc1)c1Cl)Nc1nc(cccc2)c2s1

InChI

InChI=1S/C14H9ClN2OS/c15-10-6-2-1-5-9(10)13(18)17-14-16-11-7-3-4-8-12(11)19-14/h1-8H,(H,16,17,18)

InChI Key

KRXNBZMOCGTCFA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00247351

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

288.76

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

3

Partition Coefficient, logP

4.345

Distribution Coefficient, logD

4.331

Water Solubility, LogSw

-4.67

Polar Surface Area

33.091

Acid Dissociation Constant (pKa)

8.88

Base Dissociation Constant (pKb)

-0.92

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

Y030-1125 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Aging Library (44940 compounds)

Anti-infective Library (19449 compounds)

Antiviral Library (67538 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with Y030-1125 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y030-1125?
Check Price and Availability of Y030-1125, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y030-1125 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y030-1125
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y030-1125
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y030-1125 available by request